Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens

Immunobiology. 2014 Aug;219(8):583-92. doi: 10.1016/j.imbio.2014.03.003. Epub 2014 Mar 20.

Abstract

Professional antigen-presenting cells (APCs), notably dendritic cells (DCs), are the most potent for expanding antigen-specific T cells ex vivo. However, the labor-intensive and expensive procedure for customized preparation of autologous APCs has hampered their broad clinical application. Artificial APC (aAPC) systems, which can be readily prepared from off-the-shelf components, have been proposed as a promising alternative to custom-made professional APCs. Here, in order to develop a novel aAPC system, we established K562 erythroleukemia cells expressing different combinations of co-stimulatory molecule ligands, CD80, CD70, and/or 4-1BB ligand (4-1BBL). When nucleofected with in vitro-generated mRNA encoding a tumor-associated antigen, MART-1, the K562 cells expressing all of CD80, CD70, and 4-1BBL were the most efficient for expansion of functional T cells specific to an HLA-A2-restricted immunodominant epitope, MART-126-35. In addition, only the K562 cells expressing all three of these co-stimulatory molecule ligands could clearly expand T cells specific to other less immunogenic antigen epitopes, gp100154-162 and Cyp1B1239-247, through transfection with in vitro generated gp100 and Cyp1B1 mRNA, respectively. These results indicated that non-redundant and synergistic effects of co-stimulation via CD28/CD80, CD27/CD70, and 4-1BB/4-1BBL might be critical for eliciting efficient expansion of T cells; co-stimulation via the 4-1BB/4-1BBL interaction might expand antigen-specific T cells by preventing apoptotic cell death triggered by specific antigens in the presence of the CD28/CD80 and CD27/CD70 signaling. Taken together, our findings suggested that this K562-based aAPC system expressing CD80, CD70, and 4-1BBL would be useful for efficiently stimulating functional antigen-specific T cells ex vivo, in particular when detailed information on the epitope specificities is unavailable.

Keywords: Antigen-presenting cell; Apoptotic cell death; Co-stimulatory molecule; T cell; Tumor-associated antigen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-1BB Ligand / immunology*
  • Antigen Presentation
  • Antigen-Presenting Cells / immunology*
  • Antigens, Neoplasm / immunology*
  • B7-1 Antigen / immunology*
  • CD27 Ligand / immunology*
  • Cell Proliferation
  • Cytochrome P-450 CYP1B1 / immunology
  • Epitopes / immunology
  • HLA-A2 Antigen / immunology
  • Humans
  • Immunodominant Epitopes / immunology
  • K562 Cells
  • Lymphocyte Activation
  • Neoplasm Proteins / immunology
  • T-Lymphocytes / immunology*

Substances

  • 4-1BB Ligand
  • Antigens, Neoplasm
  • B7-1 Antigen
  • CD27 Ligand
  • Epitopes
  • HLA-A2 Antigen
  • Immunodominant Epitopes
  • MART-1-Melan-A(27-35) epitope
  • Neoplasm Proteins
  • CYP1B1 protein, human
  • Cytochrome P-450 CYP1B1